Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast CancerNicholas C. Turner, Komal Jhaveri, Peter Schmid et al.|New England Journal of Medicine|2024Cited by 235
Overall Survival with Inavolisib in <i>PIK3CA</i> -Mutated Advanced Breast CancerKomal Jhaveri, Nicholas C. Turner, Seock‐Ah Im et al.|New England Journal of Medicine|2025Cited by 79
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureEirini Thanopoulou, Valentina Guarneri, Leila Khader et al.|Cancers|2020Cited by 35